BridgeBio Pharma, Inc. (BBIO)
BBIO price $67.72 +0.17 +0.24%
- Ticker
- BBIO
- Price
- $67.72
- Change
- +0.17 +0.24%
- Market cap
- $13.24B
- P/E
- -18.87
- Forward P/E
- 18.54
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A…